I am a radiation oncologist who specializes in caring for people with cancers of the chest, known as thoracic cancers. These include lung cancers, pleural mesotheliomas, and thymomas. I work closely with a highly skilled team of experts from many areas — including surgeons, medical oncologists, radiologists, medical physicists, and radiation therapists — to determine the best treatment options for my patients. We use advanced techniques including intensity-modulated radiation therapy and image-guided radiation therapy to precisely target cancers while limiting damage to normal tissues. I see nearly 400 patients each year at Memorial Sloan Kettering’s Manhattan facilities.
We have made great progress in treating thoracic cancers with radiation. Some of the techniques we have pioneered at MSK are being adopted by other large academic cancer centers. We are also at work on a number of clinical trials specifically for thoracic patients.
When patients first come to see me, I try to help them understand how radiation oncology works. They may have concerns about the treatment and side effects, but their fears tend to dissipate when I explain that radiation is a localized treatment, similar to surgery, and that side effects are usually only at the area of treatment. I hope that after meeting with me, patients and their caregivers feel calm and have a better understanding of what the process is like. I especially enjoy when they later tell me that everything happened exactly as I explained it would!
Outside of work, I’m very interested in other cultures, classical music, and hiking.
- Clinical Expertise: Thoracic Malignancies
- Awards and Honors: ITMIG Barbara Neibauer Award (2014); IMIG New Young Investigator award (2012)
- Languages Spoken: English; German
- Education: MD, Eberhard-Karls-Universitat Tubingen
- Residencies: Radiation Oncology - Memorial Sloan Kettering Cancer Center
- Board Certifications: Radiation Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Andreas Rimner
- A Phase I Study of Stereotactic Body Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer
- A Phase II Study of Nintedanib plus Prednisone to Treat Radiation Pneumonitis
- A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
- A Study Assessing the Predictive Value of Tumor Hypoxia (Low Oxygen Supply) in Patients with Non-Small Cell Lung Cancer
- Calypso-Based Deep Inspiration Breath Hold Radiation Treatment for Lung Cancer
Clinical Trials Co-Investigated by Andreas Rimner
- A Phase II Study Assessing PET/CT Scanning to Guide Radiation Treatment for Inoperable Stage III Non-Small Cell Lung Cancer
- A Phase II/III Study to See if Avoiding the Hippocampus during Whole-Brain Radiation Therapy Prevents Memory and Thinking Problems in People with Small Cell Lung Cancer
- A Phase III Study of Chemotherapy with Either Proton Therapy or Conventional Photon Radiation Therapy to Treat Inoperable Stage II-IIIB Non-Small Cell Lung Cancer
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more